Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats.

Ralf Weiskirchen; Martin Hennenberg

doi:10.3410/f.1280976.746092

Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. — Ralf Weiskirchen | RDL Network

Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats.

Discussion(0)

Related publications

Faculty Opinions recommendation of Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.

Faculty Opinions recommendation of Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.

Faculty Opinions recommendation of Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

Faculty Opinions recommendation of Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.

Faculty Opinions recommendation of Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction.